Global Lyme Disease Testing Competitive Landscape Professional Research Report 2025
Description
Global Lyme Disease Testing Competitive Landscape Professional Research Report 2025
Research Summary
Lyme disease testing refers to the diagnostic procedures used to detect the presence of Lyme disease, a tick-borne illness caused by the bacterium Borrelia burgdorferi. The primary method of Lyme disease testing involves serological tests that detect antibodies produced by the immune system in response to the infection. The most common serological tests include the enzyme immunoassay (EIA) and the Western blot test. The EIA is typically used as a screening test and if positive or equivocal, the Western blot test is performed to confirm the diagnosis. These tests detect specific antibodies against the Lyme disease bacteria. However, it is essential to note that the accuracy of these tests can vary, and false-negative results are possible, especially during the early stages of infection when antibody levels may be low. In some cases, additional laboratory tests, such as polymerase chain reaction (PCR) testing or culture of the bacteria, may be used to directly detect the presence of the bacterium in blood, joint fluid, or tissues. The interpretation of test results should be done in conjunction with clinical symptoms and exposure history to ensure accurate diagnosis and appropriate treatment of Lyme disease. Consulting with a healthcare professional is crucial for proper testing and interpretation.
According to DIResearch's in-depth investigation and research, the global Lyme Disease Testing market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Lyme Disease Testing include Quidel Corporation, Roche Holding AG, Fujirebio(H.U. Group Holdings), ZEUS Scientific, IGeneX, Thermo Fisher Scientific, Everlywell, Oxford Immunotec Global PLC(PerkinElmer), Bio-Rad Laboratories, BioMerieux, T1 Biosystems etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Lyme Disease Testing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Lyme Disease Testing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Lyme Disease Testing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Lyme Disease Testing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Lyme Disease Testing Include:
Quidel Corporation
Roche Holding AG
Fujirebio(H.U. Group Holdings)
ZEUS Scientific
IGeneX
Thermo Fisher Scientific
Everlywell
Oxford Immunotec Global PLC(PerkinElmer)
Bio-Rad Laboratories
BioMerieux
T1 Biosystems
Lyme Disease Testing Product Segment Include:
ELISA
Western Blotting
PCR
Others
Lyme Disease Testing Product Application Include:
Hospital and Testing Agency
Personal
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Lyme Disease Testing Industry PESTEL Analysis
Chapter 3: Global Lyme Disease Testing Industry Porter’s Five Forces Analysis
Chapter 4: Global Lyme Disease Testing Major Regional Market Size and Forecast Analysis
Chapter 5: Global Lyme Disease Testing Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Lyme Disease Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Lyme Disease Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Lyme Disease Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Lyme Disease Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Lyme Disease Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Lyme Disease Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Lyme Disease Testing Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Lyme Disease Testing Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Lyme Disease Testing Product by Type
- 1.2.1 ELISA
- 1.2.2 Western Blotting
- 1.2.3 PCR
- 1.2.4 Others
- 1.3 Lyme Disease Testing Product by Application
- 1.3.1 Hospital and Testing Agency
- 1.3.2 Personal
- 1.4 Global Lyme Disease Testing Market Size Analysis (2020-2032)
- 1.5 Lyme Disease Testing Market Development Status and Trends
- 1.5.1 Lyme Disease Testing Industry Development Status Analysis
- 1.5.2 Lyme Disease Testing Industry Development Trends Analysis
- 2 Lyme Disease Testing Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Lyme Disease Testing Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Lyme Disease Testing Market Analysis by Regions
- 4.1 Lyme Disease Testing Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Lyme Disease Testing Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Lyme Disease Testing Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Lyme Disease Testing Revenue Forecast by Region (2026-2032)
- 5 Global Lyme Disease Testing Market Size by Type and Application
- 5.1 Global Lyme Disease Testing Market Size by Type (2020-2032)
- 5.2 Global Lyme Disease Testing Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Lyme Disease Testing Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Lyme Disease Testing Market Size by Type
- 6.4 North America Lyme Disease Testing Market Size by Application
- 6.5 North America Lyme Disease Testing Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Lyme Disease Testing Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Lyme Disease Testing Market Size by Type
- 7.4 Europe Lyme Disease Testing Market Size by Application
- 7.5 Europe Lyme Disease Testing Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Lyme Disease Testing Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Lyme Disease Testing Market Size by Type
- 8.4 China Lyme Disease Testing Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Lyme Disease Testing Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Lyme Disease Testing Market Size by Type
- 9.4 APAC (excl. China) Lyme Disease Testing Market Size by Application
- 9.5 APAC (excl. China) Lyme Disease Testing Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Lyme Disease Testing Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Lyme Disease Testing Market Size by Type
- 10.4 Latin America Lyme Disease Testing Market Size by Application
- 10.5 Latin America Lyme Disease Testing Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Lyme Disease Testing Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Lyme Disease Testing Market Size by Type
- 11.4 Middle East & Africa Lyme Disease Testing Market Size by Application
- 11.5 Middle East & Africa Lyme Disease Testing Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Lyme Disease Testing Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Lyme Disease Testing Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Lyme Disease Testing Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Quidel Corporation
- 13.1.1 Quidel Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Quidel Corporation Lyme Disease Testing Product Portfolio
- 13.1.3 Quidel Corporation Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Roche Holding AG
- 13.2.1 Roche Holding AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Roche Holding AG Lyme Disease Testing Product Portfolio
- 13.2.3 Roche Holding AG Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Fujirebio(H.U. Group Holdings)
- 13.3.1 Fujirebio(H.U. Group Holdings) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product Portfolio
- 13.3.3 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 ZEUS Scientific
- 13.4.1 ZEUS Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 ZEUS Scientific Lyme Disease Testing Product Portfolio
- 13.4.3 ZEUS Scientific Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 IGeneX
- 13.5.1 IGeneX Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 IGeneX Lyme Disease Testing Product Portfolio
- 13.5.3 IGeneX Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Thermo Fisher Scientific
- 13.6.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Thermo Fisher Scientific Lyme Disease Testing Product Portfolio
- 13.6.3 Thermo Fisher Scientific Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Everlywell
- 13.7.1 Everlywell Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Everlywell Lyme Disease Testing Product Portfolio
- 13.7.3 Everlywell Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Oxford Immunotec Global PLC(PerkinElmer)
- 13.8.1 Oxford Immunotec Global PLC(PerkinElmer) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product Portfolio
- 13.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Bio-Rad Laboratories
- 13.9.1 Bio-Rad Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Bio-Rad Laboratories Lyme Disease Testing Product Portfolio
- 13.9.3 Bio-Rad Laboratories Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 BioMerieux
- 13.10.1 BioMerieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 BioMerieux Lyme Disease Testing Product Portfolio
- 13.10.3 BioMerieux Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 T1 Biosystems
- 13.11.1 T1 Biosystems Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 T1 Biosystems Lyme Disease Testing Product Portfolio
- 13.11.3 T1 Biosystems Lyme Disease Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Lyme Disease Testing Industry Chain Analysis
- 14.2 Lyme Disease Testing Industry Raw Material and Suppliers Analysis
- 14.2.1 Lyme Disease Testing Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Lyme Disease Testing Typical Downstream Customers
- 14.4 Lyme Disease Testing Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
